chronic obstructive lung disease smokers lung
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: male or female aged > 39 years stable COPD naïve to the study inhalers
Exclusion criteria
Exclusion criteria: clinical significant disease, particular body malformations of diseases affecting coordination and/or motor system (e.g. malformations or lack of upper extremities, Any disease that may affect the proper handling of the inhalers (Wilson*s disease, Stroke, Parkinson, Huntington*s Chorea...) ;unable to read product package instructions and to answer questionnaires
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary variable is the percentage of patients who prefer the new inhaler at visit 2. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secundary outcome ease of use convenience ease of learning to use ease of holding ease of operating ease of preparation of the dose feedback to indicate correct inhalation dosage | — |
Countries
Netherlands